Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive May 1, 2005 Margaret Buck	Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing.
Bio-IT World November 19, 2004 Lentini & Bent	Intellectual Property: Patents and Genomic Medicine Patents, so critical to encouraging investment in developing new technologies, threaten to become a legal and economic minefield that could prevent effective commercial exploitation of genomics.
Pharmaceutical Executive August 1, 2005 Jill Wechsler	Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development.
Bio-IT World November 2005 Khaleeli & Fernandez	Patent Prosecution and Enforcement in Pharmacogenomics Patenting the composition of an isolated nucleic acid sequence, an isolated protein, and small molecules is possible, but there are challenges claiming that they resulted from pharmacogenomic research.
Bio-IT World November 12, 2002 Beth E. Arnold	Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield.
National Defense June 2008 Jerry Stouck	Right and Wrong Ways To Use Others' Patents By statute, the military and other government agencies have the right to use any patented invention to further valid government missions, and this right may be extended to government contractors.
The Motley Fool June 15, 2005 Brian Gorman	Patented Drugs Fair Game in R&D The Supreme Court's ruling could be bad news for investors in small pharma and biotech.
Bio-IT World November 2005 Patrick R. Scanlon	Patent Term Extension Primer U.S. patent law includes provisions for extending the patent term of medical devices and pharmaceuticals in instances when lengthy FDA approval is taking place during the term.
Information Today May 2006 George H. Pike	Feature: BlackBerry: Lawsuit and Patent Reform Whether through the courts or before Congress, the BlackBerry experience suggests that some modification of patent law is not only likely, it's necessary.
Bio-IT World June 17, 2004 Cathryn Campbell	Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more.
Information Today September 15, 2011 George H. Pike	Congress Enacts Patent Reform Legislation In what is being described as the most substantial overhaul of U.S. patent law in nearly 60 years, Congress passed the Leahy-Smith America Invents Act, patent reform legislation that has been years in the making.
Pharmaceutical Executive March 1, 2011	A Rule of Thumb Gets Shot Down The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process.
Knowledge@Wharton	Drug Companies and the Patent Game: Fair Play or Foul? Is legal maneuvering a legitimate attempt by the big pharmaceutical companies to recover the huge costs of developing new drugs? Or are the brand-name firms inappropriately gaming the system for their own benefit, to the detriment of consumers and insurance companies?
The Motley Fool September 23, 2008 Brian Lawler	Will Generic Biologics Get Special Treatment? While the rest of the market was lost in the financial meltdown, a little-noticed report discussing some of the biopharmaceutical bills going through Congress was released.
IEEE Spectrum March 2006 Kirk Teska	The Story Behind the BlackBerry Case A single filing with the U.S. Patent and Trademark Office in 1991 has caused one of the largest patent disputes in recent memory, threatening to sever more than 3 million BlackBerry subscribers from their wireless e-mail service.
Bio-IT World November 12, 2002 Andrew W. Torrance	After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
InternetNews April 9, 2009 Stuart J. Johnston	Microsoft's Patent Tab: $388M Ought to Do It Jury finds that Microsoft infringed a California company's activation software patent to the tune of nearly $400 million.
IndustryWeek August 1, 2006	Patents: Eleven Issues To Consider... How patent savvy are you?
The Motley Fool December 29, 2006 Brian Lawler	Sirna Decides to Take the Cash and Run Shareholders vote to approve Merck's buyout offer. Investors in shares of Merck really have to trust management to have done its due diligence on Sirna and to have faith in its technology.
InternetNews September 29, 2009	Judge Overturns Uniloc Verdict and $388M Fine Microsoft could win the equivalent of a damages trifecta across several cases if its luck keeps up.
Chemistry World March 4, 2013 Andy Extance	UK considers patent rule change for trials The UK has announced plans to amend aspects of its patent law that may be encouraging pharma companies to run their clinical trials in other countries.
The Motley Fool September 12, 2005 M.D. Mitchell	Big Problems for Big Pharma Creating new drugs is never easy, but the companies that excel in three key areas are the ones for investors to watch.
The Motley Fool March 13, 2008 Stephen Albainy-Jenei	Pfizer's Celebrex Aches and Pains The Court of Appeals for the Federal Circuit upholds a lower court's ruling that found Teva Pharmaceutical had infringed two of Pfizer's patents for Celebrex.
Pharmaceutical Executive March 1, 2007	Thought Leader: Joseph Brindisi, Kyowa Pharmaceuticals For discovery shops like Kyowa Pharmaceutical, which rely on optimizing the value of compounds in development, managing the pipeline and patent life is a major concern.
The Motley Fool August 31, 2011 John Grgurich	How the Patent Wars Are Hurting High-Tech Well-intentioned patent laws are threatening to stifle innovation.
Chemistry World March 23, 2012 Rebecca Trager	Court throws out patent covering drug dosing The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented because they are based on laws of nature.
The Motley Fool October 3, 2007 Rich Duprey	No Patents on Thinking ... Yet Over the years, the U.S. Patent office has patented a few too many ideas. The Supreme Court is now spending more time deciding whether a company has really infringed on a patent, rather than automatically issuing an infringement.
The Motley Fool March 3, 2010 Brian Orelli	Judge's Ruling Has Brand and Generic Drugmakers Smiling A ruling on the patents on Merck's blood pressure medications Cozaar and Hyzaar benefited both Merck and the plaintiff in the suit, generic-drug maker Teva Pharmaceuticals. The defendant in the suit wasn't actually Merck but the Food and Drug Administration.
CIO August 1, 2003 Lawrence Rosen	Patents: An Expensive Tax on the CIO Software patents cost you money. Like taxes, they skim from your profit margins, but in this case the fees go to pay for other companies' intellectual property.
The Motley Fool March 7, 2007 Rich Duprey	Eisai Courts Danger The start of a patent-infringement trial sets the stage for the Japanese pharmaceutical's loss of protection on a major drug.
The Motley Fool February 2, 2010 Brian Orelli	Shaking Up the Biotech Industry A judge will decide if genes are patentable or not.
Bank Technology News March 2001 John Hackett	In Pursuit of Patents Bankers and their suppliers fear fallout from an over-burdened Patent and Trade Office...
InternetNews March 2, 2005 Susan Kuchinskas	Back to Court for Eolas and Microsoft A federal appeals court sends the patent infringement case back down for another trial.
InternetNews September 19, 2007 Caron Carlson	Same Patent Fight, New Patent Challenges NTP finds itself back in the patent-litigation spotlight, except it might not be as bright.
InternetNews May 20, 2005 Sean Michael Kerner	A Primer on Software Patents A closer look at software patents and at their history and implications for IT.
CIO September 28, 2012 Kim S. Nash	Companies Race to the Patent Office to Protect Their IT Breakthroughs There's a patent gold rush under way as savvy companies seek to lock in the competitive advantage from their IT innovations. CIOs ought to seek patents for unique business methods and other inventions made possible by new technology.
BusinessWeek January 9, 2006 Michael Orey	The Patent Epidemic Overpatenting is wasting companies' money and slowing the development of new products.
The Motley Fool April 3, 2007 Brian Lawler	Merck Gets the Combo Merck gets marketing approval for a diabetes combination drug. Investors, take note.
Information Today May 2004 George H. Pike	You Can't Do That, It's Patented There are an increasing number of questionable patent claims that cover Internet technologies and techniques, and permission must be obtained for their use.
Chemistry World September 2007 Derek Lowe	Column: In the Pipeline Will Phase Zero trials actually help drug development?
CIO September 28, 2011 Grant Gross	Controversial Business-Method Patents Face New Attacks A new law revamps the patent system and gives rivals an eight-year window to challenge IT-related patents in the financial-services industry.
InternetNews October 4, 2004 Jim Wagner	Sun's Java Infringes on Kodak Patents A jury in Rochester, N.Y., found Sun Microsystems liable for using patented technology owned by photography company Eastman Kodak in the Java programming language.
Information Today September 6, 2012 Paula J. Hane	Apple-Samsung Case Highlights America's Troubled Patent System The jury finding in this case has triggered an onslaught of commentary and has also brought up many questions about the nature of the U.S. patent system. The comments have ranged from "software patents are evil" to the U.S. has a "broken patent system."
The Motley Fool September 7, 2007 Brian Orelli	Merck Says No to This Protein An FDA advisory panel recommends unanimous approval of a new HIV drug from Merck. The new class of HIV medications fight the virus by blocking one key protein from entering cells.
InternetNews June 19, 2006 Andy Patrizio	Microsoft Loses Another Round in Excel Patent Case A United States Court of Appeals for the Federal Circuit upheld a patent infringement verdict against Microsoft from last year, and as Microsoft protests, the bill piles up.
Bank Technology News January 2004 Karen Krebsbach	Bight Ideas Financial services firms are deluging the U.S. Patent and Trademark Office with applications, which soared 15-fold between 1995 and 2002. Patent attorney Dale Lazar urges banks to get in line: converting valuable ideas into assets can pay off big time.
Bank Systems & Technology May 24, 2007 Maria Bruno-Britz	Banks Need Patents, Experts Say In light of recent patent litigation, banks must understand the importance of protecting their innovations.
Information Today July 2, 2013 George H. Pike	Why Patent Litigation Was on the Upswing in 2012 2012 was a "banner year in patent litigation," with increases in the number of patent infringement lawsuits filed in the federal courts and larger damage awards.
The Motley Fool May 21, 2009 Robert Steyer	The AstraZeneca Dilemma Can AstraZeneca produce enough new drugs to offset a series of upcoming patent expirations?